| Precious Jewel Moses, LVN | |
|
14608 Yukon Ave, Suite 23, Hawthorne, CA 90250-8542 | |
| (323) 474-1436 | |
| (424) 456-7323 |
| Full Name | Precious Jewel Moses |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 14608 Yukon Ave, Hawthorne, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750650867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 235621 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Precious Jewel Moses, LVN 14608 Yukon Ave, Suite 23, Hawthorne, CA 90250-8542 Ph: (323) 474-1436 | Precious Jewel Moses, LVN 14608 Yukon Ave, Suite 23, Hawthorne, CA 90250-8542 Ph: (323) 474-1436 |
News Archive
The researchers how physicians examined claims of lower back back pain and note that part of the "rising economic cost of this epidemic is the burgeoning use of indiscriminate imaging," specifically MRIs. Researchers divided patients into two groups and "the treating physician in group 1 patients was blinded to the MRI results, while the physician for group 2 patients decided on treatment after reviewing the MRI findings."
How easy is it for older individuals to understand what their doctor tells them or to evaluate whether health information in the media is reliable? A new study on older Finnish people's health literacy found that one third of 75-year-old Finns find it difficult to understand and use health-related information.
Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
A protein known for its ability to "bridge" interactions between other cellular proteins may spur metastasis in breast cancer, the disease's deadliest stage, a study from Burnham Institute for Medical Research has found.
› Verified 5 days ago